Skip to main content
Log in

Reply to: Lung Cancer in Young Patients: The Importance of Assessing Driver Mutations and Treatment Strategies

  • AUTHOR'S RESPONSE
  • Published:
Lung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Galvez-Nino M, Ruiz R, Pinto JA, Roque K, Mantilla R, Raez LE et al (2019) Lung cancer in the young. Lung. https://doi.org/10.1007/s00408-019-00294-5

    Article  PubMed  Google Scholar 

  2. Liu B, Quan X, Xu C, Lv J, Li C, Dong L, Liu M (2019) Lung cancer in young adults aged 35 years or younger: a full-scale analysis and review. J Cancer 10:3553–3559. https://doi.org/10.7150/jca.27490

    Article  PubMed  PubMed Central  Google Scholar 

  3. Yoneyama R, Saji H, Kato Y, Kudo Y, Shimada Y, Kimura M, Hagiwara M, Kakihana M, Miyajima K, Kajiwara N, Ohira T (2019) Clinicopathological characteristics and treatment strategies for young lung cancer patients. Ann Transl Med 7:100. https://doi.org/10.21037/atm.2019.01.69

    Article  PubMed  PubMed Central  Google Scholar 

  4. Arnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ et al (2016) Lung cancer in the very young: treatment and survival in the national cancer data base. J Thorac Oncol 11:1121–1131

    Article  Google Scholar 

  5. Jiang W, Kang Y, Shi G-Y, Zhang H-Y, Cai L, Sun X-W et al (2012) Comparisons of multiple characteristics between young and old lung cancer patients. Chin Med J 125:72–80

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Galvez‑Nino.

Ethics declarations

Conflict of interest

The author declares no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This reply refers to the comment available online at https://doi.org/10.1007/s00408-020-00326-5

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galvez‑Nino, M. Reply to: Lung Cancer in Young Patients: The Importance of Assessing Driver Mutations and Treatment Strategies. Lung 198, 427–428 (2020). https://doi.org/10.1007/s00408-020-00338-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-020-00338-1

Navigation